CEC Capital advises Zhongkexinyang on 100-million-yuan private financing roundPUBT·1 day ago, 07:09 PM
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-RezLondon Stock Exchange·Jul 28 at 05:06 AMGSK-0.73%03692-0.49%
Shouyao Holdings: RET inhibitor Sotorasib tablets (SY-5007) new drug application has been acceptedZhitong·Oct 22, 2025 at 05:15 AM688197+1.26%
Zhitong A-share lock-up release overview | September 23Zhitong·Sep 22, 2025 at 08:01 PM300860+5.26%603383+3.58%
Shouyao Holdings: Net profit loss of 104 million yuan in the first half of 2025Zhitong·Aug 27, 2025 at 04:14 AM688197+1.26%
The three major A-share indices of the Shanghai and Shenzhen markets rose by 0.6% to 2.8% in the first half of the day, with brokerage and innovative drug concept stocks gainingAASTOCKS·Aug 12, 2025 at 10:30 PM002653+3.88%688197+1.26%
Multiple high-priced stocks experienced adjustments today, with Forest Packaging and Forms Syntron dropping over 8%Zhitong·Jul 21, 2025 at 01:19 AM300468+1.00%300950+1.09%
Innovative drug concept stocks continue to be strong, Konruns hits the limit upZhitong·Jul 10, 2025 at 08:38 PM688197+1.26%603590+0.88%
The concept of innovative drugs surged and then fell back, with Hob Biotech dropping over 10%Zhitong·Jun 12, 2025 at 09:12 PM688197+1.26%688068+4.55%
Shouyao Holdings: Plans to invest no more than 787 million yuan to build a new drug research and development and industrialization base projectZhitong·Apr 27, 2025 at 08:20 AM688197+1.26%
Shouyao Holdings released its first-quarter performance, with a net loss attributable to the parent company of 50.751 million yuan, narrowing the lossZhitong·Apr 27, 2025 at 03:25 AM688197+1.26%
The innovative drug concept is repeatedly active, and BHC has hit the daily limitZhitong·Mar 27, 2025 at 08:53 PM688197+1.26%688068+4.55%
